Hippocratic AI, a healthcare-focused artificial intelligence startup, has secured $53 million in Series A funding, elevating its valuation to $500 million. The funding round was led by prominent investors including General Catalyst, Andreessen Horowitz (a16z) Bio + Health, and Premji Invest, with participation from health systems such as Memorial Hermann Health System, Cincinnati Children’s, WellSpan Health, Universal Health Services (UHS), HonorHealth, and OhioHealth. Founded by entrepreneur Munjal Shah alongside a team of physicians, hospital administrators, and AI researchers from institutions like El Camino Health, Johns Hopkins, and Stanford, the company aims to develop the first large language model tailored specifically for healthcare applications.
The newly acquired capital will be utilized to advance safety testing and accelerate product development, particularly focusing on non-diagnostic, patient-facing services. Hippocratic AI’s initial offerings include generative AI-powered agents designed to perform tasks such as chronic care management, post-discharge follow-ups for conditions like congestive heart failure and kidney disease, wellness assessments, and pre-operative outreach. These AI agents are intended to address the significant shortage of healthcare professionals, including nurses, social workers, and nutritionists, by providing scalable solutions to enhance patient care and operational efficiency within the healthcare system.